RS55515B1 - Postupak pripremanja pemetrekseda i njegovih lizinskih soli - Google Patents
Postupak pripremanja pemetrekseda i njegovih lizinskih soliInfo
- Publication number
- RS55515B1 RS55515B1 RS20161202A RSP20161202A RS55515B1 RS 55515 B1 RS55515 B1 RS 55515B1 RS 20161202 A RS20161202 A RS 20161202A RS P20161202 A RSP20161202 A RS P20161202A RS 55515 B1 RS55515 B1 RS 55515B1
- Authority
- RS
- Serbia
- Prior art keywords
- pemetrexed
- mixture
- salt
- lysine
- water
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000398A ITRM20120398A1 (it) | 2012-08-08 | 2012-08-08 | Procedimento di sintesi pemetrexed e suo sale di lisina. |
| PCT/IB2013/056497 WO2014024164A1 (en) | 2012-08-08 | 2013-08-08 | Process for the preparation of pemetrexed and lysin salt thereof |
| EP13777144.0A EP2882753B1 (en) | 2012-08-08 | 2013-08-08 | Process for the preparation of pemetrexed and lysin salt thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS55515B1 true RS55515B1 (sr) | 2017-05-31 |
Family
ID=47018368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20161202A RS55515B1 (sr) | 2012-08-08 | 2013-08-08 | Postupak pripremanja pemetrekseda i njegovih lizinskih soli |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP2882753B1 (en:Method) |
| KR (1) | KR102288417B1 (en:Method) |
| CN (1) | CN104736540B (en:Method) |
| AU (1) | AU2013301156B2 (en:Method) |
| BR (1) | BR112015002429A8 (en:Method) |
| CY (1) | CY1118514T1 (en:Method) |
| DK (1) | DK2882753T3 (en:Method) |
| ES (1) | ES2607890T3 (en:Method) |
| HR (1) | HRP20170011T1 (en:Method) |
| HU (1) | HUE032304T2 (en:Method) |
| IN (1) | IN2015DN00833A (en:Method) |
| IT (1) | ITRM20120398A1 (en:Method) |
| LT (1) | LT2882753T (en:Method) |
| MX (1) | MX362858B (en:Method) |
| PL (1) | PL2882753T3 (en:Method) |
| PT (1) | PT2882753T (en:Method) |
| RS (1) | RS55515B1 (en:Method) |
| RU (1) | RU2609006C2 (en:Method) |
| SI (1) | SI2882753T1 (en:Method) |
| SM (2) | SMT201600474T1 (en:Method) |
| TW (1) | TWI609017B (en:Method) |
| WO (1) | WO2014024164A1 (en:Method) |
| ZA (1) | ZA201501549B (en:Method) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107641124A (zh) * | 2016-07-22 | 2018-01-30 | 上海创诺制药有限公司 | 一种培美曲塞二酸新晶型及其制备方法 |
| CN109836425B (zh) * | 2017-11-24 | 2023-01-24 | 江苏创诺制药有限公司 | 一种合成培美酸的制备工艺 |
| US11779584B2 (en) | 2018-02-07 | 2023-10-10 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated pemetrexed and uses thereof |
| CA3090483A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated pemetrexed and uses thereof |
| CN110128428A (zh) * | 2018-02-09 | 2019-08-16 | 鲁南制药集团股份有限公司 | 培美曲塞丙氨酸盐 |
| CN110128426B (zh) * | 2018-02-09 | 2021-12-14 | 鲁南制药集团股份有限公司 | 培美曲塞谷氨酸盐 |
| CN110128427A (zh) * | 2018-02-09 | 2019-08-16 | 鲁南制药集团股份有限公司 | 培美曲塞缬氨酸盐 |
| CN111333658A (zh) * | 2020-05-06 | 2020-06-26 | 贵州联科中贝制药科技有限公司 | 一种培美曲塞二钠水合物的制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68918951T2 (de) | 1988-10-31 | 1995-03-16 | Mitsui Toatsu Chemicals | Verfahren zur herstellung eines mit einer organischen gruppe substituierten natriumaluminiumhydrids. |
| KR0162654B1 (ko) | 1989-12-11 | 1998-11-16 | 알렌 제이. 시니스갤리 | N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체 |
| IL96531A (en) | 1989-12-11 | 1995-08-31 | Univ Princeton | History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them) |
| US5416211A (en) | 1992-09-25 | 1995-05-16 | Eli Lilly And Company | Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines |
| CZ283281B6 (cs) * | 1992-09-25 | 1998-02-18 | Eli Lilly And Company | Způsob přípravy v poloze 5 substituovaných pyrrolo(2,3-d)pyrimidinů |
| DE19725647A1 (de) | 1997-06-18 | 1998-12-24 | Basf Ag | Cyclopenta[I]phenanthren-Metallkomplex-Katalysatorsysteme |
| ZA987550B (en) | 1997-09-26 | 2000-02-21 | Lilly Co Eli | Processes and intermediates useful to make antifolates. |
| DE60100750T2 (de) | 2000-02-25 | 2004-07-29 | Eli Lilly And Co., Indianapolis | NEUE KRISTALLINE FORM VON N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]-PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMINSÄURE UND VERFAHREN FÜR IHRE HERSTELLUNG |
| WO2008021410A2 (en) * | 2006-08-14 | 2008-02-21 | Sicor Inc. | Highly pure pemetrexed diacid and processes for the preparation thereof |
| ES2555154T3 (es) | 2006-08-14 | 2015-12-29 | Sicor, Inc. | Procesos para la preparación de intermedios del pemetrexed |
| CN101591247B (zh) * | 2008-05-30 | 2012-09-05 | 上海希迪制药有限公司 | 合成4-(4-甲酯基苯基)丁醛的方法 |
| IT1401677B1 (it) * | 2010-07-22 | 2013-08-02 | Chemi Spa | Nuovo processo per la sintesi di pemetrexed sale disodico |
| WO2012015810A2 (en) | 2010-07-28 | 2012-02-02 | Eagle Pharmaceuticals, Inc. | Pharmaceutical compositions containing pemetrexed having extended storage stability |
| WO2012056285A1 (en) * | 2010-10-25 | 2012-05-03 | Fresenius Kabi Oncology Ltd. | An improved process for the preparation of pemetrexed |
-
2012
- 2012-08-08 IT IT000398A patent/ITRM20120398A1/it unknown
-
2013
- 2013-08-06 TW TW102128058A patent/TWI609017B/zh active
- 2013-08-08 MX MX2015001712A patent/MX362858B/es active IP Right Grant
- 2013-08-08 HU HUE13777144A patent/HUE032304T2/en unknown
- 2013-08-08 EP EP13777144.0A patent/EP2882753B1/en active Active
- 2013-08-08 PL PL13777144T patent/PL2882753T3/pl unknown
- 2013-08-08 AU AU2013301156A patent/AU2013301156B2/en active Active
- 2013-08-08 IN IN833DEN2015 patent/IN2015DN00833A/en unknown
- 2013-08-08 RS RS20161202A patent/RS55515B1/sr unknown
- 2013-08-08 HR HRP20170011TT patent/HRP20170011T1/hr unknown
- 2013-08-08 WO PCT/IB2013/056497 patent/WO2014024164A1/en not_active Ceased
- 2013-08-08 SM SM20160474T patent/SMT201600474T1/it unknown
- 2013-08-08 KR KR1020157005932A patent/KR102288417B1/ko active Active
- 2013-08-08 RU RU2015108042A patent/RU2609006C2/ru active
- 2013-08-08 SI SI201330427A patent/SI2882753T1/sl unknown
- 2013-08-08 BR BR112015002429A patent/BR112015002429A8/pt not_active Application Discontinuation
- 2013-08-08 DK DK13777144.0T patent/DK2882753T3/en active
- 2013-08-08 ES ES13777144.0T patent/ES2607890T3/es active Active
- 2013-08-08 CN CN201380041935.8A patent/CN104736540B/zh active Active
- 2013-08-08 LT LTEP13777144.0T patent/LT2882753T/lt unknown
- 2013-08-08 PT PT137771440T patent/PT2882753T/pt unknown
-
2015
- 2015-03-06 ZA ZA2015/01549A patent/ZA201501549B/en unknown
-
2016
- 2016-12-28 CY CY20161101351T patent/CY1118514T1/el unknown
- 2016-12-28 SM SM201600474T patent/SMT201600474B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013301156B2 (en) | 2017-08-31 |
| ZA201501549B (en) | 2016-01-27 |
| HK1209426A1 (en) | 2016-04-01 |
| PL2882753T3 (pl) | 2017-04-28 |
| CY1118514T1 (el) | 2017-07-12 |
| EP2882753A1 (en) | 2015-06-17 |
| SMT201600474B (it) | 2017-03-08 |
| MX362858B (es) | 2019-02-20 |
| SI2882753T1 (sl) | 2017-02-28 |
| RU2609006C2 (ru) | 2017-01-30 |
| LT2882753T (lt) | 2016-12-12 |
| SMT201600474T1 (it) | 2017-03-08 |
| BR112015002429A2 (pt) | 2017-07-04 |
| ITRM20120398A1 (it) | 2014-02-09 |
| CN104736540B (zh) | 2017-08-25 |
| IN2015DN00833A (en:Method) | 2015-06-12 |
| TW201412741A (zh) | 2014-04-01 |
| WO2014024164A1 (en) | 2014-02-13 |
| ES2607890T3 (es) | 2017-04-04 |
| CN104736540A (zh) | 2015-06-24 |
| DK2882753T3 (en) | 2017-01-16 |
| TWI609017B (zh) | 2017-12-21 |
| MX2015001712A (es) | 2015-08-14 |
| PT2882753T (pt) | 2016-12-27 |
| EP2882753B1 (en) | 2016-10-05 |
| KR20150045458A (ko) | 2015-04-28 |
| BR112015002429A8 (pt) | 2019-07-30 |
| KR102288417B1 (ko) | 2021-08-11 |
| AU2013301156A1 (en) | 2015-02-05 |
| HRP20170011T1 (hr) | 2017-03-10 |
| RU2015108042A (ru) | 2016-09-27 |
| HUE032304T2 (en) | 2017-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS55515B1 (sr) | Postupak pripremanja pemetrekseda i njegovih lizinskih soli | |
| EP2970123B1 (en) | Salt of omecamtiv mecarbil and process for preparing salt | |
| WO2011019986A2 (en) | Processes for preparing pemetrexed | |
| JP6374436B2 (ja) | 純粋なエルロチニブ | |
| JP2024161449A (ja) | ヤヌスキナーゼ阻害剤の結晶形 | |
| US20160251314A1 (en) | 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof | |
| JP5826371B2 (ja) | ペメトレキセド塩の製造方法 | |
| ES2892161T3 (es) | Preparación de derivados de ácido 2-([1,2,3]triazol-2-il)-benzoico | |
| WO2012098501A1 (en) | Febuxostat co-crystals | |
| US20210300917A1 (en) | Solid State Forms of an Apoptosis-Inducing Agent and Processes Thereof | |
| MX2014001756A (es) | Compuesto de sal y polimorfo de pirazolopirimidinona, y composición farmacéutica que lo contiene, método de preparación y uso del mismo. | |
| HK1209426B (en) | Process for the preparation of pemetrexed and lysin salt thereof | |
| EP1598347A1 (en) | Polymorphs of pantoprazole sodium salt and process for the preparation thereof | |
| HK1167647B (en) | 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof | |
| HK1210080A1 (en) | Sulfate of 5-hydroxy-1h-imidazole-4-carboxamide | |
| HK1218544B (en) | Salt of omecamtiv mecarbil and process for preparing salt |